Goldman Sachs Group Inc Tandem Diabetes Care Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 620,546 shares of TNDM stock, worth $20.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
620,546
Previous 191,724 223.67%
Holding current value
$20.2 Million
Previous $7.72 Million 240.64%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$35.21 - $47.3 $15.1 Million - $20.3 Million
428,822 Added 223.67%
620,546 $26.3 Million
Q2 2024

Aug 13, 2024
BUY
$30.43 - $53.43 $2.22 Million - $3.89 Million
72,887 Added 61.33%
191,724 $7.72 Million
Q1 2024

May 15, 2024
SELL
$22.09 - $35.41 $2.36 Million - $3.78 Million
-106,888 Reduced 47.35%
118,837 $4.21 Million
Q4 2023

Feb 13, 2024
BUY
$14.28 - $31.03 $2.07 Million - $4.5 Million
144,910 Added 179.31%
225,725 $6.68 Million
Q3 2023

May 14, 2024
SELL
$19.33 - $36.22 $2.8 Million - $5.25 Million
-144,910 Reduced 64.2%
80,815 $1.68 Million
Q3 2023

Nov 14, 2023
SELL
$19.33 - $36.22 $58,318 - $109,275
-3,017 Reduced 3.6%
80,815 $1.68 Million
Q2 2023

May 14, 2024
SELL
$24.18 - $42.46 $1.51 Million - $2.66 Million
-62,646 Reduced 42.77%
83,832 $2.06 Million
Q2 2023

Aug 14, 2023
SELL
$24.18 - $42.46 $1.51 Million - $2.66 Million
-62,646 Reduced 42.77%
83,832 $2.06 Million
Q1 2023

May 14, 2024
SELL
$35.86 - $46.5 $7 Million - $9.08 Million
-195,216 Reduced 57.13%
146,478 $5.95 Million
Q1 2023

May 11, 2023
SELL
$35.86 - $46.5 $7 Million - $9.08 Million
-195,216 Reduced 57.13%
146,478 $5.95 Million
Q4 2022

May 14, 2024
BUY
$35.49 - $56.15 $1.81 Million - $2.87 Million
51,072 Added 17.57%
341,694 $15.4 Million
Q4 2022

Feb 13, 2023
BUY
$35.49 - $56.15 $1.81 Million - $2.87 Million
51,072 Added 17.57%
341,694 $15.4 Million
Q3 2022

May 14, 2024
SELL
$43.76 - $68.97 $14.7 Million - $23.2 Million
-336,664 Reduced 53.67%
290,622 $13.9 Million
Q3 2022

Nov 10, 2022
SELL
$43.76 - $68.97 $14.7 Million - $23.2 Million
-336,664 Reduced 53.67%
290,622 $13.9 Million
Q2 2022

May 14, 2024
BUY
$53.22 - $123.09 $21.4 Million - $49.4 Million
401,561 Added 177.9%
627,286 $37.1 Million
Q2 2022

Aug 15, 2022
SELL
$53.22 - $123.09 $8.93 Million - $20.7 Million
-167,827 Reduced 21.11%
627,286 $37.1 Million
Q1 2022

May 16, 2022
SELL
$101.89 - $150.09 $13.7 Million - $20.1 Million
-134,178 Reduced 14.44%
795,113 $92.5 Million
Q4 2021

Feb 14, 2022
SELL
$118.18 - $153.21 $6.32 Million - $8.19 Million
-53,455 Reduced 5.44%
929,291 $140 Million
Q3 2021

Nov 10, 2021
BUY
$93.51 - $129.4 $91.9 Million - $127 Million
982,746 New
982,746 $117 Million

Others Institutions Holding TNDM

# of Institutions
361
Shares Held
72.5M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.09B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email